We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$1.9M
Cap. Flow
-$30.9M
Cap. Flow %
-9.55%
Top 10 Hldgs %
61.81%
Holding
89
New
17
Increased
17
Reduced
13
Closed
9

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$6.97M
2
ORIC icon
Oric Pharmaceuticals
ORIC
+$5.93M
3
MPLT
MapLight Therapeutics
MPLT
+$5.48M
4
PAYO icon
Payoneer
PAYO
+$4.81M
5
LENZ
LENZ Therapeutics
LENZ
+$4.37M

Top Sells

Rank Stock Value
1
EVCM icon
EverCommerce
EVCM
+$18.3M
2
ROIV icon
Roivant Sciences
ROIV
+$14.3M
3
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$13.5M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$6.9M
5
IRON icon
Disc Medicine
IRON
+$6.76M

Sector Composition

Rank Sector Weight
1 Healthcare 63.81%
2 Financials 18.18%
3 Technology 8.81%
4 Consumer Discretionary 7.9%
5 Energy 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
26
Pliant Therapeutics
PLRX
$65M
$3.62M 1.12%
2,969,199
– –
CNTA
27
DELISTED
Centessa Pharmaceuticals
CNTA
$3.49M 1.08%
139,450
-30,000
-18% -$760K
AQST icon
28
Aquestive Therapeutics
AQST
$494M
$3.39M 1.05%
525,000
-725,000
-58% -$4.52M
CMPS
29
Compass Pathways
CMPS
$1.83B
$3.24M 1%
469,914
-135,000
-22% -$823K
ADCT icon
30
ADC Therapeutics
ADCT
$144M
$2.93M 0.91%
733,568
– –
ELDN icon
31
Eledon Pharmaceuticals
ELDN
$285M
$2.91M 0.9%
1,929,912
+950,000
+97% +$2.26M
NU icon
32
Nu Holdings
NU
$66.9B
$2.91M 0.9%
173,873
– –
LENZ
33
LENZ Therapeutics
LENZ
$168M
$2.4M 0.74%
+150,000
New +$4.37M
MLYS icon
34
Mineralys Therapeutics
MLYS
$2.41B
$2.39M 0.74%
65,944
-35,000
-35% -$1.4M
NIOBW
35
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$1.66M 0.51%
876,148
+329,706
+60% +$824K
JANX icon
36
Janux Therapeutics
JANX
$967M
$1.38M 0.43%
+100,000
New +$2.35M
CHYM
37
Chime Financial
CHYM
$11B
$1M 0.31%
+39,886
New +$847K
EPD icon
38
Enterprise Products Partners
EPD
$81.7B
$1M 0.31%
31,290
– –
FLD
39
Fold Holdings
FLD
$24.9M
$985K 0.3%
856,632
– –
MRKR icon
40
Marker Therapeutics
MRKR
$18.7M
$826K 0.25%
554,250
– –
DRTSW icon
41
Alpha Tau Medical Warrant
DRTSW
$79.6M
$396K 0.12%
+1,166,118
New +$393K
CAH icon
42
Cardinal Health
CAH
$55.4B
$353K 0.11%
1,718
– –
DAIC
43
CID HoldCo Inc
DAIC
$934K
$251K 0.08%
+22,294
New +$1.15M
OMDA
44
Omada Health Inc
OMDA
$1.41B
$243K 0.07%
+15,377
New +$312K
TTAN
45
ServiceTitan Inc
TTAN
$8.19B
$241K 0.07%
2,266
-2,688
-54% -$263K
RZLVW
46
Rezolve AI Warrants
RZLVW
$5.64M
$240K 0.07%
289,309
-3,621
-1% -$4.33K
PIPR icon
47
Piper Sandler
PIPR
$5.29B
$206K 0.06%
2,428
– –
OPTXW icon
48
Syntec Optics Holdings Warrant
OPTXW
$19.2M
$193K 0.06%
803,132
– –
AMOD
49
Alpha Modus Holdings
AMOD
$22.1M
$181K 0.06%
9,852
– –
BNAIW
50
Brand Engagement Network Warrant
BNAIW
$1.97M
$109K 0.03%
2,726,276
+1,059,468
+64% +$62.9K
1
2
3 4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q4 2025 Portfolio in Review

As of Q4 2025, Blue Owl Capital Holdings held 89 positions worth $324M, up 0.59% from $322M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Blue Owl Capital Holdings withdrew a net $30.9M in Q4 2025, closing 9 positions and reducing 13 holdings. Its most notable exit was EverCommerce, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 57% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Procore worth $6.86M.

  • Blue Owl Capital Holdings's largest Q4 2025 buy was Procore: 94,264 shares worth $6.86M.
  • Blue Owl Capital Holdings added most to Compass Therapeutics in Q4 2025, an estimated $4.04M increase.
  • Blue Owl Capital Holdings's biggest Q4 2025 reduction was Roivant Sciences, cutting an estimated $14.3M.
  • Blue Owl Capital Holdings fully exited EverCommerce in Q4 2025, selling an estimated $18.3M.
  • Blue Owl Capital Holdings's ten largest holdings make up 62% of its $324M portfolio in Q4 2025.
  • Blue Owl Capital Holdings opened 17 new positions and closed 9 in Q4 2025.
  • Blue Owl Capital Holdings's portfolio value rose 0.59% quarter-over-quarter to $324M.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2025, filed 9 Feb 2026.